Abstract
The aim of the present study was to survey the prevalence of antipsychotic polypharmacy and combined medication use across 15 Asian countries and areas in 2016. By using the results from the fourth survey of Research on Asian Prescription Patterns on antipsychotics, the rates of polypharmacy and combined medication use in each country were analyzed. Daily medications prescribed for the treatment of inpatients or outpatients with schizophrenia, including antipsychotics, mood stabilizers, anxiolytics, hypnotics, and antiparkinson agents, were collected. Fifteen countries from Asia participated in this study. A total of 3744 patients' prescription forms were examined. The prescription patterns differed across these Asian countries, with the highest rate of polypharmacy noted in Vietnam (59.1%) and the lowest in Myanmar (22.0%). Furthermore, the combined use of other medications, expressed as highest and lowest rate, respectively, was as follows: mood stabilizers, China (35.0%) and Bangladesh (1.0%); antidepressants, South Korea (36.6%) and Bangladesh (0%); anxiolytics, Pakistan (55.7%) and Myanmar (8.5%); hypnotics, Japan (61.1%) and, equally, Myanmar (0%) and Sri Lanka (0%); and antiparkinson agents, Bangladesh (87.9%) and Vietna...Continue Reading
References
Jan 1, 1987·Schizophrenia Bulletin·S R KayL A Opler
Jan 1, 1974·Journal of Psychiatric Research·J M Davis
Aug 24, 1999·The Journal of Clinical Psychiatry·S M Stahl
Sep 21, 2002·Lancet·Nori TakeiUNKNOWN JPSS-2 research group
Jun 26, 2003·The Journal of Clinical Psychiatry·Scott W Woods
May 14, 1959·The New England Journal of Medicine·D G FRIEND
Nov 25, 2003·The Journal of Clinical Psychiatry·Oliver Freudenreich, Donald C Goff
Jul 17, 2004·British Journal of Clinical Pharmacology·Kang SimChay H Tan
Sep 7, 2006·International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care·Onyebuchi A ArahNiek S Klazinga
Apr 18, 2008·Schizophrenia Bulletin·Christoph U CorrellStefan Leucht
Aug 16, 2008·International Clinical Psychopharmacology·Michela NosèCorrado Barbui
Jan 6, 2010·Archives of General Psychiatry·Ramin Mojtabai, Mark Olfson
Apr 7, 2010·The Journal of Clinical Psychiatry·Ric M ProcyshynAlasdair M Barr
Oct 7, 2010·The Journal of Clinical Psychiatry·John M Kane, Christoph U Correll
Mar 23, 2011·Schizophrenia Research·Christoph U CorrellJohn M Kane
Oct 13, 2011·Pharmacopsychiatry·Y-T XiangN Shinfuku
Dec 17, 2011·Pharmacopsychiatry·M ShinfukuS Kapur
Apr 18, 2012·Acta Psychiatrica Scandinavica·Stephen M Stahl
Mar 15, 2013·Revista de psiquiatrí́a y salud mental·Stephen M Stahl
Nov 23, 2013·Hernia : the Journal of Hernias and Abdominal Wall Surgery·Y W Kim, I Y Kim
Feb 5, 2014·Schizophrenia Bulletin·Stefan LeuchtJohn M Davis
Jun 14, 2014·The Australian and New Zealand Journal of Psychiatry·Qian LiTian-Mei Si
Dec 1, 2014·BMC Psychiatry·Maxine D FisherKathleen F Villa
Jan 21, 2015·Psychiatry and Clinical Neurosciences·Toshiya Inada, Ataru Inagaki
Mar 12, 2015·International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care·F CarinciUNKNOWN OECD Health Care Quality Indicators Expert Group
Apr 5, 2015·Schizophrenia Bulletin·Stefan LeuchtJohn M Davis
Apr 20, 2016·Schizophrenia Research·Giouliana KadraRichard D Hayes
Apr 28, 2016·BMC Health Services Research·Yasuhiko Hashimoto, Masami Tensho
Jun 7, 2017·BJPsych Bulletin·Bret A MooreStephen M Stahl
Citations
Apr 19, 2019·Biological & Pharmaceutical Bulletin·Shinya SuzukiHisamitsu Takase
Aug 23, 2019·Psychiatry and Clinical Neurosciences·Yoshikazu TakaesuRyota Hashimoto
Feb 23, 2019·BMC Psychiatry·J Carmona-HuertaR Medina-Dávalos
Dec 24, 2019·The International Journal of Neuropsychopharmacology·Shih-Ku Lin
May 19, 2020·Human Psychopharmacology·Kentaro MatsuiKen Inada
Jul 1, 2020·Neuropsychopharmacology Reports·Kayo IchihashiRyota Hashimoto
Jul 17, 2020·Neuropsychopharmacology Reports·Norio Yasui-Furukori, Kazutaka Shimoda
Dec 31, 2019·Community Mental Health Journal·Samer HammoudehHassen Al-Amin
Jun 13, 2020·Frontiers in Psychiatry·Christian Farrell, Johann Brink
Dec 31, 2020·Drug Design, Development and Therapy·Yoshinori WatanabeToshiaki Kikuchi
Mar 12, 2021·Neuropsychopharmacology Reports·Shusuke NumataRyota Hashimoto
Apr 20, 2021·Frontiers in Oncology·Celeste L Y EwigYin Ting Cheung
Jun 11, 2021·Journal of Clinical Psychopharmacology·Nobutaka AyaniJin Narumoto
Jul 30, 2021·Asian Journal of Psychiatry·Naoki HashimotoRyota Hashimoto
Jul 28, 2021·CNS Drugs·Kai-Chun YangYa-Mei Bai
Sep 15, 2021·Asia-Pacific Psychiatry : Official Journal of the Pacific Rim College of Psychiatrists·Naotaka Shinfuku
Nov 5, 2021·Psychiatry Investigation·Yukako NakagamiTakahiro A Kato
Oct 21, 2021·Journal of Clinical Psychopharmacology·Fuminari MisawaHiroyoshi Takeuchi